A cultural practice of drinking realgar wine leading to elevated urinary arsenic and its potential health risk

Environment International

Volumn 37, Issue 5, 2011, Pages 889-892

  Zhang, Ying Nan ^a   Sun, Guo Xin ^a   Huang, Qing ^b   Williams, Paul N ^a,c   Zhu, Yong Guan ^a,b  

^a RESEARCH CENTER FOR ECO ENVIRONMENTAL SCIENCES   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

Arsenic; Health; Realgar wine; Urine

Indexed keywords

BODY FLUIDS; HEALTH; HEALTH RISKS; PAINT; WINE;

ARSENIC CONCENTRATION; AVERAGE CONCENTRATION; CULTURAL PRACTICES; MONITORING PERIODS; PAINT APPLICATIONS; POTENTIAL HEALTH RISKS; RISK TO HUMAN HEALTH; URINE;

ARSENIC;

ARSENIC DERIVATIVE; REALGAR; UNCLASSIFIED DRUG;

ABSORPTION; ARSENIC; HEALTH RISK; URINE;

ADULT; ARTICLE; CHILD; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURAL PERIOD; DRINKING; FACE; FEMALE; HEALTH HAZARD; HUMAN; INGESTION; MALE; PAINTING; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; URINALYSIS; URINE LEVEL; VOLUNTEER; WINE;

ASIA;

EID: 79955623601     PISSN: 01604120     EISSN: 18736750     Source Type: Journal    
DOI: 10.1016/j.envint.2011.02.020     Document Type: Article

References (48)

1. Buchet J.P., Lauwerys R.R. Study of inorganic arsenic methylation by rat liver in vitro: relevance for the interpretation of observations in man. Arch Toxicol 1985, 57:125-129.
2. Cascio C., Raab A., Jenkins R.O., Feldmann J., Meharg A.A., Haris P.I. The impact of a rice based diet on urinary arsenic 2011, 10.1039/c0em00482k.
3. Cheraghali A.M., Haghqoo S., Shalviri G., Shariati Y.R., Ghassemi M., Khosravi S. Fatalities following skin exposure to arsenic. Clin Toxicol 2007, 45:965-967.
4. Cullen W.R. Is arsenic an aphrodisiac?. The Sociochemistry of an Element 2008.
5. Dart R.C. Medical toxicology 2004, Lippincott Williams and Wilkins, New York. Third ed.
6. Deng J.F., Wu M.L., Tsai W.J., Ger J., Yang C.C. Acute realgar herbal poisoning - two cases report. Toxicol Lett 1998, 95:73.
7. Dhawan M., Flora S.J.S., Tandon S.K. Biochemical changes and essential metal concentration in lead intoxicated rats preexposed to ethanol. Alcohol 1992, 9:241-245.
8. Dutkiewicz T. Experimental studies on arsenic absorption routes in rats. Environ Health Persp 1977, 19:173-177.
9. Ernst E., Thompson Coon J. Heavy metals in traditional Chinese medicines: a systematic review. Clin Pharmacol Ther 2001, 70:497-504.
10. Flora S.J., Pant S.C., Malhotra P.R., Kannan G.M. Biochemical and histopathological changes in arsenic-intoxicated rats coexposed to ethanol. Alcohol 1997, 14:563-568.
11. Heitland P., Koster H.D. Comparison of different medical cases in urinary arsenic speciation by fast HPLC-ICP-MS. Int J Hyg Environ Health 2009, 212:432-438.
12. Hinwood A.L., Sim M.R., Jolley D., de Klerk N., Bastone E.B., Gerostamoulos J., Drummer O.H. Exposure to inorganic arsenic in soil increases urinary inorganic arsenic concentrations of residents living in old mining areas. Environ Geochem Health 2004, 26:27-36.
13. Hostynek J.J., Hinz R.S., Lorence C.R., Price M., Guy R.H. Metals and the skin. Crit Rev Toxicol 1993, 23:171-235.
14. Hostynek J.J. Factors determining percutaneous metal absorption. Food Chem Toxicol 2003, 41:327-345.
15. Hughes M.F., Mitchell C.T., Edwards B.C., Rahman M.S. In vitro percutaneous absorption of dimethylarsinic acid in mice. J Toxicol Environ Health 1995, 45:279-290.
16. Hwang Y.H., Bornschein R.L., Grote J., Menrath W., Roda S. Environmental arsenic exposure of children around a former copper smelter site. Environ Res 1997, 72:72-81.
17. Johnson J.E., Kissel J.C. Prevalence of dermal pathway dominance in risk assessment of contaminated soils: a survey of superfund risk assessments, 1989-1992. Hum Ecol Risk Assess 1996, 2:356-365.
18. Klatsky A.L. Alcohol and cardiovascular diseases: a historical overview. Ann NY Acad Sci 2002, 957:7-15.
19. Koch I., Sylvester S., Lai V.W.M., Owen A., Reimer K.J., Cullen W.R. Bioaccessibility and excretion of arsenic in Niu Huang Jie Du Pian pills. Toxicol Appl Pharm 2007, 222:357-364.
20. Kurttio P., Komulainen H., Hakala E., Kahelin H., Pekkanen J. Urinary excretion of arsenic species after exposure to arsenic present in drinking water. Arch Environ Contam Toxicol 1998, 34:297-305.
21. Le X.C., Cullen W.R., Reimer K.J. Human urinary arsenic excretion after one-time ingestion of seaweed, crab, and shrimp. Clin Chem 1994, 40:617-624.
22. Lee J.J., Kim Y.K., Cho S.H., Park K.S., Chung I.J., Cho D., Ryang D.W., Kim H.J. Hemolytic anemia as a sequelae of arsenic intoxication following long-term ingestion of traditional Chinese medicine. J Korean Med Sci 2004, 19:127-129.
23. Li X., Pi J.B., Li B., Xu Y.Y., Jin Y.P., Sun G.F. Urinary arsenic speciation and its correlation with 8-OHdG in Chinese residents exposed to arsenic through coal burning. Bull Environ Contam Toxicol 2008, 81:406-411.
24. Liu J., Lu Y., Wu Q., Goyer R.A., Waalkes M.P. Mineral arsenicals in traditional medicines: orpiment, realgar, and arsenolite. J Pharmacol Exp Ther 2008, 326:363-368.
25. Lowney Y.W., Ruby M.V., Wester R.C., Schoof R.A., Holm S.E., Hui X.Y., Barbadillo S., Maibach H.I. Percutaneous absorption of arsenic from environmental media. Toxicol Ind Health 2005, 21:1-14.
26. Lowney Y.W., Wester R.C., Schoof R.A., Cushing C.A., Edwards M., Ruby M.V. Dermal absorption of arsenic from soils as measured in the rhesus monkey. Toxicol Sci 2007, 100:381-392.
27. Lu D.P., Qiu J.Y., Jiang B., Wang Q., Liu K.Y., Liu Y.R., Chen S.S. Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report. Blood 2002, 99:3136-3143.
28. Nico P.S., Ruby M.V., Lowney Y.W., Holm S.E. Chemical speciation and bioaccessibility of arsenic and chromium in chromated copper arsenate-treated wood and soils. Environ Sci Technol 2006, 40:402-408.
29. NRC Arsenic in drinking water 1999, National Research Council, Washington, DC.
30. Ouypornkochagorn S., Feldmann J. Dermal uptake of arsenic through human skin depends strongly on its speciation. Environ Sci Technol 2010, 44:3972-3978.
31. Roskos K.V., Guy R.H., Maibach H.I. Percutaneous absorption in the aged. Dermatol Clin 1986, 4:455-465.
32. Roskos K.V., Maibach H.I., Guy R.H. The effect of aging on percutaneous absorption in man. J Dermatol 1989, 16:475-479.
33. Rougier A., Dupuis D., Lotte C., Roguet R., Wester R.C., Maibach H.I. Regional variation in percutaneous absorption in man: measurement by the stripping method. Arch Dermatol Res 1986, 278:465-469.
34. Scheuplein R.J., Blank I.H. Mechanism of percutaneous absorption IV. penetration of nonelectrolytes (ahcohols) from aqueous solutions and from pure liquids. J Invest Dermatol 1973, 60:286-296.
35. Sirot V., Guérin T., Volatier J.L., Leblanc J.C. Dietary exposure and biomarkers of arsenic in consumers of fish and shellfish from France. Sci Total Environ 2009, 407:1875-1885.
36. Suzuki K.T., Mandal B.K., Ogra Y. Speciation of arsenic in body fluids. Talanta 2002, 58:111-119.
37. Tandon S.K., Tewari P.C. Effect of co-exposure to ethanol and cadmium in rats. Bull Environ Contarn Toxicol 1987, 39:633-640.
38. Tang Y.S., Wang L.S. Pharmacokinetic studies of arsenic-containing traditional medicines. Zhong Yao Cai 2005, 12:1130-1135.
39. The national standards of the People's Republic of China (GB 2762-2005) Maximum levels of contaminants in foods 2005.
40. Tseng C.H. A review on environmental factors regulating arsenic methylation in humans. Toxicol Appl Pharm 2009, 235:338-350.
41. Wahlberg J.E. Nickel: the search for alternative, optimal and non-irritant patch test preparations. assessment based on laser Doppler flow metry. Skin Res Technol 1996, 2:136-141.
42. Wei L.P., Wu R.A., Yang X.Q., Dong X.X. Medication leads to chronic arsenic poisoning: a case report. J Clin Dermatol 2002, 31:525-526.
43. Wester R.C., Hui X., Barbadillo S., Maibach H.I., Lowney Y.W., Schoof R.A., Holm S.E., Ruby M.V. In vivo percutaneous absorption of arsenic from water and CCA-treated wood residue. Toxicol Sci 2004, 79:287-295.
44. Wester R.C., Maibach H.I., Sedik L., Melendres J., Wade M. In vivo and in vitro percutaneous absorption and skin decontamination of arsenic from water and soil. Toxicol Sci 1993, 20:336-340.
45. Wester R.C., Maibach H.I. Regional variation in percutaneous absorption. Percutaneous Absorption: Mechanisms-Methodology-Drug Delivery 1980, Marcel Dekker. R.L. Bronaugh, H.I. Maibach (Eds.).
46. WHO Arsenic and arsenic compounds. Environmental Health Criteria 224 2001, World Health Organization, Geneva.
47. Wu J.Z., Ho P.C. Evaluation of the in vitro activity and in vivo bioavailability of realgar nanoparticles prepared by cryo-grinding. Eur J Pharm Sci 2006, 29:35-44.
48. Zhu Y.G., Sun G.X., Lei M., Teng M., Liu Y.X., Chen N.C., Wang L.H., Carey A.M., Deacon C., Raab A., Meharg A.A., Williams P.N. High percentage inorganic arsenic content of mining impacted and nonimpacted Chinese rice. Environ Sci Technol 2008, 42:5008-5013.